-
Fund Dashboard
- Holdings
T. Rowe Price Health Sciences Portfolio
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
LLY Eli Lilly and Company | 67.88 mm | 87.93 k shares | 10.20 | Common equity | Long | USA |
UNH UnitedHealth Group Incorporated | 40.61 mm | 80.29 k shares | 6.10 | Common equity | Long | USA |
ISRG Intuitive Surgical, Inc. | 38.49 mm | 73.75 k shares | 5.78 | Common equity | Long | USA |
TMO Thermo Fisher Scientific Inc. | 30.30 mm | 58.24 k shares | 4.55 | Common equity | Long | USA |
SYK Stryker Corporation | 27.68 mm | 76.87 k shares | 4.16 | Common equity | Long | USA |
DHR Danaher Corporation | 24.76 mm | 107.86 k shares | 3.72 | Common equity | Long | USA |
ARGENX SE
|
24.40 mm | 39.67 k shares | 3.67 | Common equity | Long | Netherlands |
MRK Merck & Co., Inc. | 17.08 mm | 171.72 k shares | 2.57 | Common equity | Long | USA |
BSX Boston Scientific Corporation | 16.61 mm | 185.92 k shares | 2.50 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals Incorporated | 15.85 mm | 39.36 k shares | 2.38 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals, Inc. | 15.22 mm | 64.66 k shares | 2.29 | Common equity | Long | USA |
ASTRAZENECA PLC
|
13.77 mm | 210.16 k shares | 2.07 | Common equity | Long | UK |
ELV Elevance Health Inc. | 12.53 mm | 33.96 k shares | 1.88 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 11.89 mm | 16.69 k shares | 1.79 | Common equity | Long | USA |
AMGN Amgen Inc. | 10.01 mm | 38.41 k shares | 1.50 | Common equity | Long | USA |
INSM Insmed Incorporated | 9.19 mm | 133.13 k shares | 1.38 | Common equity | Long | USA |
Cigna Holding Co | 8.88 mm | 32.14 k shares | 1.33 | Common equity | Long | USA |
BDX Becton, Dickinson and Company | 8.11 mm | 35.75 k shares | 1.22 | Common equity | Long | USA |
BPMC Blueprint Medicines Corporation | 7.54 mm | 86.50 k shares | 1.13 | Common equity | Long | USA |
PEN Penumbra, Inc. | 7.19 mm | 30.26 k shares | 1.08 | Common equity | Long | USA |
ASND Ascendis Pharma A/S | 7.01 mm | 50.92 k shares | 1.05 | Common equity | Long | Denmark |
ONC BeiGene, Ltd. | 6.71 mm | 36.34 k shares | 1.01 | Common equity | Long | Cayman Islands |
SNY Sanofi | 6.61 mm | 137.13 k shares | 0.99 | Common equity | Long | France |
T. Rowe Price Government Reserve Fund | 5.15 mm | 5.15 mm shares | 0.77 | Short-term investment vehicle | Long | USA |
HCA HCA Healthcare, Inc. | 4.93 mm | 16.42 k shares | 0.74 | Common equity | Long | USA |
UTHR United Therapeutics Corporation | 4.80 mm | 13.60 k shares | 0.72 | Common equity | Long | USA |
SRRK Scholar Rock Holding Corporation | 4.70 mm | 108.82 k shares | 0.71 | Common equity | Long | USA |
PCVX Vaxcyte, Inc. | 4.59 mm | 56.11 k shares | 0.69 | Common equity | Long | USA |
MOH Molina Healthcare, Inc. | 4.35 mm | 14.95 k shares | 0.65 | Common equity | Long | USA |
NTRA Natera, Inc. | 4.23 mm | 26.71 k shares | 0.64 | Common equity | Long | USA |
MLTX MoonLake Immunotherapeutics | 4.23 mm | 78.08 k shares | 0.64 | Common equity | Long | Cayman Islands |
THC Tenet Healthcare Corporation | 4.11 mm | 32.57 k shares | 0.62 | Common equity | Long | USA |
SONOVA HOLDING AG
|
3.90 mm | 11.92 k shares | 0.59 | Common equity | Long | Switzerland |
RNA Avidity Biosciences, Inc. | 3.73 mm | 128.22 k shares | 0.56 | Common equity | Long | USA |
RVMD Revolution Medicines, Inc. | 3.73 mm | 85.17 k shares | 0.56 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 3.69 mm | 27.03 k shares | 0.55 | Common equity | Long | USA |
BIOHAVEN LTD
|
3.58 mm | 95.77 k shares | 0.54 | Common equity | Long | Virgin Islands (British) |
EW Edwards Lifesciences Corporation | 3.50 mm | 47.26 k shares | 0.53 | Common equity | Long | USA |
ACLX Arcellx, Inc. | 3.42 mm | 44.63 k shares | 0.51 | Common equity | Long | USA |
CHUGAI PHARMACEUTICAL CO LTD
|
3.38 mm | 76.70 k shares | 0.51 | Common equity | Long | Japan |
EXAS Exact Sciences Corporation | 3.37 mm | 59.95 k shares | 0.51 | Common equity | Long | USA |
A Agilent Technologies, Inc. | 3.16 mm | 23.53 k shares | 0.47 | Common equity | Long | USA |
CRNX Crinetics Pharmaceuticals, Inc. | 2.96 mm | 57.93 k shares | 0.45 | Common equity | Long | USA |
CNTA Centessa Pharmaceuticals plc | 2.91 mm | 173.58 k shares | 0.44 | Common equity | Long | UK |
KYMR Kymera Therapeutics, Inc. | 2.75 mm | 68.30 k shares | 0.41 | Common equity | Long | USA |
TECH Bio-Techne Corporation | 2.74 mm | 38.09 k shares | 0.41 | Common equity | Long | USA |
NATIONAL RESILIENCE SER B CVT PFD STOCK | 2.52 mm | 54.25 k shares | 0.38 | Preferred equity | Long | USA |
IDXX IDEXX Laboratories, Inc. | 2.48 mm | 6.00 k shares | 0.37 | Common equity | Long | USA |
MDGL Madrigal Pharmaceuticals, Inc. | 2.44 mm | 7.91 k shares | 0.37 | Common equity | Long | USA |
DGX Quest Diagnostics Incorporated | 2.36 mm | 15.67 k shares | 0.36 | Common equity | Long | USA |
ZAI LAB LTD
|
2.36 mm | 90.02 k shares | 0.35 | Common equity | Long | Cayman Islands |
RVTY Revvity, Inc. | 2.23 mm | 19.98 k shares | 0.33 | Common equity | Long | USA |
CAH Cardinal Health, Inc. | 2.12 mm | 17.93 k shares | 0.32 | Common equity | Long | USA |
CNC Centene Corporation | 2.10 mm | 34.66 k shares | 0.32 | Common equity | Long | USA |
NVO Novo Nordisk A/S | 2.09 mm | 24.32 k shares | 0.31 | Common equity | Long | Denmark |
KRYS Krystal Biotech, Inc. | 2.05 mm | 13.11 k shares | 0.31 | Common equity | Long | USA |
DXCM DexCom, Inc. | 2.00 mm | 25.74 k shares | 0.30 | Common equity | Long | USA |
PTGX Protagonist Therapeutics, Inc. | 1.99 mm | 51.43 k shares | 0.30 | Common equity | Long | USA |
OSCR Oscar Health, Inc. | 1.98 mm | 147.08 k shares | 0.30 | Common equity | Long | USA |
HOLX Hologic, Inc. | 1.97 mm | 27.36 k shares | 0.30 | Common equity | Long | USA |
COR Cencora | 1.94 mm | 8.63 k shares | 0.29 | Common equity | Long | USA |
ALKERMES PLC
|
1.91 mm | 66.47 k shares | 0.29 | Common equity | Long | Ireland |
PRCT PROCEPT BioRobotics Corporation | 1.90 mm | 23.56 k shares | 0.28 | Common equity | Long | USA |
SARTORIUS AG | 1.84 mm | 8.26 k shares | 0.28 | Preferred equity | Long | Germany |
NOVOCURE LTD
|
1.83 mm | 61.37 k shares | 0.27 | Common equity | Long | Jersey |
APGE Apogee Therapeutics, Inc. | 1.80 mm | 39.73 k shares | 0.27 | Common equity | Long | USA |
RGEN Repligen Corporation | 1.79 mm | 12.41 k shares | 0.27 | Common equity | Long | USA |
MCK McKesson Corporation | 1.75 mm | 3.06 k shares | 0.26 | Common equity | Long | USA |
BTSG BrightSpring Health Services, Inc. Common Stock | 1.69 mm | 99.30 k shares | 0.25 | Common equity | Long | USA |
AGIO Agios Pharmaceuticals, Inc. | 1.69 mm | 51.40 k shares | 0.25 | Common equity | Long | USA |
IMCR Immunocore Holdings plc | 1.66 mm | 56.20 k shares | 0.25 | Common equity | Long | UK |
DNLI Denali Therapeutics Inc. | 1.63 mm | 79.76 k shares | 0.24 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals, Inc. | 1.59 mm | 45.45 k shares | 0.24 | Common equity | Long | USA |
CYTK Cytokinetics, Incorporated | 1.59 mm | 33.74 k shares | 0.24 | Common equity | Long | USA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
1.47 mm | 66.70 k shares | 0.22 | Common equity | Long | Israel |
HUM Humana Inc. | 1.33 mm | 5.26 k shares | 0.20 | Common equity | Long | USA |
SWTX SpringWorks Therapeutics, Inc. | 1.32 mm | 36.45 k shares | 0.20 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 1.31 mm | 31.23 k shares | 0.20 | Common equity | Long | USA |
AKRO Akero Therapeutics, Inc. | 1.27 mm | 45.82 k shares | 0.19 | Common equity | Long | USA |
BIIB Biogen Inc. | 1.25 mm | 8.18 k shares | 0.19 | Common equity | Long | USA |
WAVE LIFE SCIENCES LTD
|
1.20 mm | 96.94 k shares | 0.18 | Common equity | Long | Singapore |
ICON PLC
|
1.20 mm | 5.71 k shares | 0.18 | Common equity | Long | Ireland |
BMRN BioMarin Pharmaceutical Inc. | 1.17 mm | 17.82 k shares | 0.18 | Common equity | Long | USA |
ORKA Oruka Therapeutics Inc. | 1.08 mm | 55.90 k shares | 0.16 | Common equity | Long | USA |
TREELINE BIO SER A-1 CVT PFD STOCK PP | 1.06 mm | 123.06 k shares | 0.16 | Preferred equity | Long | USA |
REPL Replimune Group, Inc. | 1.03 mm | 85.04 k shares | 0.15 | Common equity | Long | USA |
LEGN Legend Biotech Corporation | 1.03 mm | 31.64 k shares | 0.15 | Common equity | Long | Cayman Islands |
GENERATE BIO SER B CVT PFD STOCK PP | 1.00 mm | 84.49 k shares | 0.15 | Preferred equity | Long | USA |
IRON Disc Medicine, Inc. | 927.29 k | 14.63 k shares | 0.14 | Common equity | Long | USA |
TREELINE BIO SER A CVT PFD STOCK PP | 913.22 k | 106.06 k shares | 0.14 | Preferred equity | Long | USA |
IMNM Immunome, Inc. | 897.81 k | 84.54 k shares | 0.13 | Common equity | Long | USA |
LNTH Lantheus Holdings, Inc. | 895.94 k | 10.02 k shares | 0.13 | Common equity | Long | USA |
NATIONAL RESILIENCE SER C CVT PFD STOCK | 893.34 k | 19.22 k shares | 0.13 | Preferred equity | Long | USA |
BCYC Bicycle Therapeutics plc | 879.84 k | 62.85 k shares | 0.13 | Common equity | Long | UK |
CRGX CARGO Therapeutics, Inc. Common Stock | 872.27 k | 60.49 k shares | 0.13 | Common equity | Long | USA |
BRKR Bruker Corporation | 855.03 k | 14.59 k shares | 0.13 | Common equity | Long | USA |
BLUEJAY THERAPEUTICS SER C CVT PFD PP | 850.15 k | 130.26 k shares | 0.13 | Preferred equity | Long | USA |
RYTM Rhythm Pharmaceuticals, Inc. | 844.12 k | 15.08 k shares | 0.13 | Common equity | Long | USA |
CARIS LIFE SCIENCES SER C CVT PFD PP | 832.84 k | 169.28 k shares | 0.13 | Preferred equity | Long | USA |
CLDX Celldex Therapeutics, Inc. | 830.14 k | 32.85 k shares | 0.12 | Common equity | Long | USA |
XNCR Xencor, Inc. | 776.72 k | 33.80 k shares | 0.12 | Common equity | Long | USA |
GPCR Structure Therapeutics Inc. | 773.06 k | 28.51 k shares | 0.12 | Common equity | Long | Cayman Islands |
DELFI DIAGNOSTICS SR A CVT PFD STOCK PP | 748.76 k | 154.53 k shares | 0.11 | Preferred equity | Long | USA |
INSITRO SER B CVT PFD PP | 727.86 k | 39.79 k shares | 0.11 | Preferred equity | Long | USA |
RCKT Rocket Pharmaceuticals, Inc. | 675.05 k | 53.70 k shares | 0.10 | Common equity | Long | USA |
CELLANOME SERIES A CVT PFD STOCK PP | 672.89 k | 89.84 k shares | 0.10 | Preferred equity | Long | USA |
ARSENAL BIOSCIENCES SER C CVT PFD PP | 650.73 k | 35.02 k shares | 0.10 | Preferred equity | Long | USA |
METSERA SER B CVT PFD STOCK PP | 648.87 k | 128.74 k shares | 0.10 | Preferred equity | Long | USA |
TXG 10x Genomics, Inc. | 644.43 k | 44.88 k shares | 0.10 | Common equity | Long | USA |
MBX BIOSCIENCES SER C CVT PFD PP | 639.28 k | 34.69 k shares | 0.10 | Preferred equity | Long | USA |
IMCR Immunocore Holdings plc | 620.44 k | 739.00 k principal | 0.09 | Debt | Long | UK |
TENAX THERAPEUTICS PRE FUNDED WTS PP
|
598.66 k | 101.92 k shares | 0.09 | Common equity | Long | USA |
DYN Dyne Therapeutics, Inc. | 569.99 k | 24.19 k shares | 0.09 | Common equity | Long | USA |
END EAVOR BIO SERIES B CVT PFD STOCK PP | 550.05 k | 84.30 k shares | 0.08 | Preferred equity | Long | USA |
CLEAR LABS SERIES C CVT PFD PP | 542.40 k | 171.44 k shares | 0.08 | Preferred equity | Long | USA |
SEAPORT THERAPEUTICS SER B CVT PFD PP | 539.70 k | 113.62 k shares | 0.08 | Preferred equity | Long | USA |
AKTIS ONCOLOGY SER B CVTPFD PP | 537.91 k | 134.48 k shares | 0.08 | Preferred equity | Long | USA |
CARIS LIFE SER D CVT PFD STOCK PP | 501.54 k | 101.94 k shares | 0.08 | Preferred equity | Long | USA |
NUTCRACKER THERA SER C CVT PFD STOCK PP | 500.66 k | 46.57 k shares | 0.08 | Preferred equity | Long | USA |
IDYA IDEAYA Biosciences, Inc. | 497.83 k | 19.37 k shares | 0.07 | Common equity | Long | USA |
KARTOS THERAPEUTICS SR C CVT PFD STK PP | 485.75 k | 85.93 k shares | 0.07 | Preferred equity | Long | USA |
INSITRO SER C CVT PFD PP | 480.73 k | 26.28 k shares | 0.07 | Preferred equity | Long | USA |
SYRE Spyre Therapeutics, Inc. | 474.45 k | 20.38 k shares | 0.07 | Common equity | Long | USA |
KARDIUM SERIES D6 CVT PFD STOCK PP | 473.03 k | 556.50 k shares | 0.07 | Preferred equity | Long | USA |
GENESIS THERA SEV B CVT PFD STOCK PP | 465.32 k | 91.10 k shares | 0.07 | Preferred equity | Long | USA |
ARVN Arvinas, Inc. | 446.78 k | 23.31 k shares | 0.07 | Common equity | Long | USA |
GLUE Monte Rosa Therapeutics, Inc. | 445.39 k | 64.18 k shares | 0.07 | Common equity | Long | USA |
OBSIDIAN THERAPEUTICS SR C CVT PFD STK PP | 422.06 k | 222.39 k shares | 0.06 | Preferred equity | Long | USA |
HLXB Helix Acquisition Corp. II Class A Ordinary Shares | 421.54 k | 40.15 k shares | 0.06 | Common equity | Long | Cayman Islands |
DELFI DIAGNOSTICS SR B CVT PFD STOCK PP | 407.53 k | 84.10 k shares | 0.06 | Preferred equity | Long | USA |
IOVA Iovance Biotherapeutics, Inc. | 402.92 k | 54.45 k shares | 0.06 | Common equity | Long | USA |
FREENOME HOLDINGS SER B CVT PFD PP | 396.25 k | 71.40 k shares | 0.06 | Preferred equity | Long | USA |
ORIC ORIC Pharmaceuticals, Inc. | 376.06 k | 46.60 k shares | 0.06 | Common equity | Long | USA |
ELEMENT BIOSCIENCES SER C CVT PFD STOCK | 375.80 k | 38.78 k shares | 0.06 | Preferred equity | Long | USA |
PLRX Pliant Therapeutics, Inc. | 362.66 k | 27.54 k shares | 0.05 | Common equity | Long | USA |
TESSERA THERAPEUTICS SR C CVT PFD STK PP | 357.36 k | 17.48 k shares | 0.05 | Preferred equity | Long | USA |
CHROMA MEDICINE SER I CVT PFD STOCK PP | 355.00 k | 355.00 k shares | 0.05 | Preferred equity | Long | USA |
APLS Apellis Pharmaceuticals, Inc. | 352.96 k | 11.06 k shares | 0.05 | Common equity | Long | USA |
VERILY LIFE SCIENCES LLC SER B UNITS PP
|
351.10 k | 5.22 k shares | 0.05 | Common equity | Long | USA |
TRDA Entrada Therapeutics, Inc. | 343.28 k | 19.85 k shares | 0.05 | Common equity | Long | USA |
KARDIUM INC SER D-5 CVT PFD STOCK PP | 343.21 k | 403.78 k shares | 0.05 | Preferred equity | Long | USA |
ALLO Allogene Therapeutics, Inc. | 341.58 k | 160.37 k shares | 0.05 | Common equity | Long | USA |
DNA SCRIPT SERIES C CVT PFD STOCK PP | 338.27 k | 1.13 k shares | 0.05 | Preferred equity | Long | France |
SALUDA MEDICAL SERIES D CVT PFD STOCK PP | 331.39 k | 31.15 k shares | 0.05 | Preferred equity | Long | USA |
PHARVARIS NV
|
316.29 k | 16.50 k shares | 0.05 | Common equity | Long | Netherlands |
CLEERLY SER C CVT PFD STK PP | 312.56 k | 26.53 k shares | 0.05 | Preferred equity | Long | USA |
GALVANIZE THERAPEUTICS CVT PROM NOTE PP | 295.30 k | 295.30 k principal | 0.04 | Debt | Long | USA |
AVALYN PHARMA SER C-1 CVT PFD STOCK PP | 284.58 k | 388.60 k shares | 0.04 | Preferred equity | Long | USA |
IGMS IGM Biosciences, Inc. | 282.07 k | 46.17 k shares | 0.04 | Common equity | Long | USA |
SCRIBE THERA SER B CVT PFD STOCK PP | 277.64 k | 45.88 k shares | 0.04 | Preferred equity | Long | USA |
PROTHENA CORP PLC
|
270.67 k | 19.54 k shares | 0.04 | Common equity | Long | Ireland |
ODYSSEY THERAPEUTICS SR B CVT PFD STK PP | 262.95 k | 50.57 k shares | 0.04 | Preferred equity | Long | USA |
REFLEXION MEDICAL INC CVT PFD SR C PP | 259.22 k | 150.71 k shares | 0.04 | Preferred equity | Long | USA |
KARDIUM INC CB CVT PROM NOTE PP | 256.50 k | 256.50 k principal | 0.04 | Debt | Long | Canada |
IMTX Immatics N.V. | 255.54 k | 35.94 k shares | 0.04 | Common equity | Long | Netherlands |
SCHOLAR ROCK WTS 12.25 PP
|
245.89 k | 6.86 k shares | 0.04 | Common equity | Long | USA |
AFFINIVAX AFX3772 MILESTONE EVENT PP
|
245.66 k | 331.98 k shares | 0.04 | Common equity | Long | USA |
EIKON THERA SERIES B CVT PFD STOCK PP | 243.55 k | 45.78 k shares | 0.04 | Preferred equity | Long | USA |
VYGR Voyager Therapeutics, Inc. | 242.74 k | 42.81 k shares | 0.04 | Common equity | Long | USA |
COLOR HEALTH SERIES D-1 CVT PFD STOCK PP | 241.78 k | 20.17 k shares | 0.04 | Preferred equity | Long | USA |
HONOR TECHNOLOGY SER D CVT PFD PP | 240.82 k | 140.83 k shares | 0.04 | Preferred equity | Long | USA |
SIONNA THERAPEUTICS SR B CVT PFD STK PP | 238.77 k | 24.46 k shares | 0.04 | Preferred equity | Long | USA |
COLOR HEALTH SER D CVT PFD STOCK PP | 235.59 k | 13.31 k shares | 0.04 | Preferred equity | Long | USA |
SALUDA MEDICAL INC SERIES E CVT PFD PP | 234.79 k | 24.28 k shares | 0.04 | Preferred equity | Long | USA |
FREENOME HOLDINGS SER C CVT PFD PP | 231.61 k | 41.73 k shares | 0.03 | Preferred equity | Long | USA |
GALVANIZE THERA CVT PROM NOTE 12/24 PP | 223.20 k | 223.20 k principal | 0.03 | Debt | Long | USA |
THIRD ARC BIO SER A CVT PFD PP | 213.73 k | 101.57 k shares | 0.03 | Preferred equity | Long | USA |
LUMICKS TECH SER D CVT PFD STOCK PP | 204.84 k | 221.00 shares | 0.03 | Preferred equity | Long | USA |
FOG PHARMA SER D CVT PFD STOCK PP | 202.26 k | 27.55 k shares | 0.03 | Preferred equity | Long | USA |
RING THERA SER B CVT PFD STOCK PP | 201.87 k | 43.89 k shares | 0.03 | Preferred equity | Long | USA |
GENERATE BIOMEDICINES INC SER C CVT PFD | 201.49 k | 17.00 k shares | 0.03 | Preferred equity | Long | USA |
RLAY Relay Therapeutics, Inc. | 201.13 k | 48.82 k shares | 0.03 | Common equity | Long | USA |
EYPT EyePoint Pharmaceuticals, Inc. | 200.10 k | 26.86 k shares | 0.03 | Common equity | Long | USA |
GENESIS THERA SER A CVT PFD STOCK PP | 191.39 k | 37.47 k shares | 0.03 | Preferred equity | Long | USA |
SANA Sana Biotechnology, Inc. | 188.53 k | 115.66 k shares | 0.03 | Common equity | Long | USA |
LYEL Lyell Immunopharma, Inc. | 182.59 k | 285.30 k shares | 0.03 | Common equity | Long | USA |
WGS GeneDx Holdings Corp. | 179.70 k | 2.34 k shares | 0.03 | Common equity | Long | USA |
FOG PHARMACEUTICALS SERIES C CVT PFD STOCK PP | 165.37 k | 19.48 k shares | 0.02 | Preferred equity | Long | USA |
AURA Aura Biosciences, Inc. | 164.98 k | 20.07 k shares | 0.02 | Common equity | Long | USA |
HONOR TECHNOLOGY SER E CVT PFD STOCK PP | 162.31 k | 94.92 k shares | 0.02 | Preferred equity | Long | USA |
PAX LABS CLASS A COMMON PP
|
158.13 k | 385.68 k shares | 0.02 | Common equity | Long | USA |
ENDEAVOR BIO SER C CVT PFD PP | 154.16 k | 23.63 k shares | 0.02 | Preferred equity | Long | USA |
REFLEXION MEDICAL INC SR E CVT PFD PP | 150.94 k | 83.86 k shares | 0.02 | Preferred equity | Long | USA |
NxStage Medical, Inc. | 148.88 k | 81.35 k shares | 0.02 | Common equity | Long | USA |
ANAB AnaptysBio, Inc. | 139.02 k | 10.50 k shares | 0.02 | Common equity | Long | USA |
FREENOME HOLDINGS SER D CVT PFD PP | 131.84 k | 23.67 k shares | 0.02 | Preferred equity | Long | USA |
AFFINIVAX NEXT GEN PROD MILESTON EVNT PP
|
122.83 k | 331.98 k shares | 0.02 | Common equity | Long | USA |
INSCRIPTA SERIES E CVT PFD STOCK PP | 121.06 k | 64.74 k shares | 0.02 | Preferred equity | Long | USA |
LARONDE SERIES B CVT PFD STOCK PP | 115.58 k | 52.54 k shares | 0.02 | Preferred equity | Long | USA |
REFLEXION MEDICAL INC PP | 109.93 k | 83.28 k shares | 0.02 | Preferred equity | Long | USA |
ELEMENT BIOSCIENCES SER D-1 CVT PFD PP | 106.32 k | 13.56 k shares | 0.02 | Preferred equity | Long | USA |
ELEMENT BIOSCIENCES SER D CVT PFD PP | 106.32 k | 13.56 k shares | 0.02 | Preferred equity | Long | USA |
- EXACT SCIENCES CMO MILESTONE PP
|
103.80 k | 167.42 k shares | 0.02 | Common equity | Long | USA |
OBIO Orchestra BioMed Holdings, Inc. | 99.13 k | 24.78 k shares | 0.01 | Common equity | Long | USA |
RING THERAPEUTICS SER C CVT PFD STK PP | 98.82 k | 21.48 k shares | 0.01 | Preferred equity | Long | USA |
ARBOR BIO SERIES B CVT PFD STOCK PP | 98.62 k | 23.99 k shares | 0.01 | Preferred equity | Long | USA |
GBIO Generation Bio Co. | 96.95 k | 91.46 k shares | 0.01 | Common equity | Long | USA |
FOG PHARMA SER E CVT PFD PP | 92.82 k | 14.90 k shares | 0.01 | Preferred equity | Long | USA |
ZNTL Zentalis Pharmaceuticals, Inc. | 91.70 k | 30.27 k shares | 0.01 | Common equity | Long | USA |
REFLEXION MEDICAL INC CVT | 89.39 k | 51.08 k shares | 0.01 | Preferred equity | Long | USA |